These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18713000)

  • 1. Insulin delivery with FlexPen: dose accuracy, patient preference and adherence.
    Pfützner A; Asakura T; Sommavilla B; Lee W
    Expert Opin Drug Deliv; 2008 Aug; 5(8):915-25. PubMed ID: 18713000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative device assessments: Humalog KwikPen compared with vial and syringe and FlexPen.
    Ignaut DA; Schwartz SL; Sarwat S; Murphy HL
    Diabetes Educ; 2009; 35(5):789-98. PubMed ID: 19783767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose accuracy comparison between SoloSTAR and FlexPen at three different dose levels.
    Penfornis A; Horvat K
    Diabetes Technol Ther; 2008 Oct; 10(5):359-62. PubMed ID: 18715211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus.
    Korytkowski M; Bell D; Jacobsen C; Suwannasari R;
    Clin Ther; 2003 Nov; 25(11):2836-48. PubMed ID: 14693308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FlexPen: addressing issues of confidence and convenience in insulin delivery.
    Korytkowski M; Niskanen L; Asakura T
    Clin Ther; 2005; 27 Suppl B():S89-100. PubMed ID: 16519040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of usability and patient preference for the new disposable insulin device Solostar versus Flexpen, lilly disposable pen, and a prototype pen: an open-label study.
    Haak T; Edelman S; Walter C; Lecointre B; Spollett G
    Clin Ther; 2007 Apr; 29(4):650-60. PubMed ID: 17617288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiating insulin therapy in type 2 diabetes: benefits of insulin analogs and insulin pens.
    Brunton S
    Diabetes Technol Ther; 2008 Aug; 10(4):247-56. PubMed ID: 18715198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the handling and accuracy of syringe and vial versus prefilled insulin pen (FlexPen).
    Asakura T; Seino H; Nakano R; Muto T; Toraishi K; Sako Y; Kageyama M; Yohkoh N
    Diabetes Technol Ther; 2009 Oct; 11(10):657-61. PubMed ID: 19821758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FlexPen for the delivery of insulin: accuracy, injection force and patient preference.
    Pfützner A
    Expert Rev Med Devices; 2009 Mar; 6(2):115-23. PubMed ID: 19298158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study on the dosing accuracy of commonly used disposable insulin pens.
    Krzywon M; van der Burg T; Fuhr U; Schubert-Zsilavecz M; Abdel-Tawab M
    Diabetes Technol Ther; 2012 Sep; 14(9):804-9. PubMed ID: 22694223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose accuracy and injection force dynamics of a novel disposable insulin pen.
    Clarke A; Spollett G
    Expert Opin Drug Deliv; 2007 Mar; 4(2):165-74. PubMed ID: 17335413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential Insulin Underdelivery from Prefilled and Reusable Insulin Pens in Cases of Premature Needle Withdrawal: A Laboratory Evaluation.
    Joubert M; Haddouche A; Morera J; Rod A; Reznik Y
    Diabetes Technol Ther; 2015 Oct; 17(10):712-6. PubMed ID: 26355757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health economics and compliance of vials/syringes versus pen devices: a review of the evidence.
    Asche CV; Shane-McWhorter L; Raparla S
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S101-8. PubMed ID: 20515297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose accuracy of SoloSTAR and FlexPen as assessed in a clinical setting.
    Friedrichs A
    Diabetes Technol Ther; 2009 Sep; 11(9):609-13. PubMed ID: 19764841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin glargine and glulisine SoloSTAR pens for the treatment of diabetes.
    Garg S; Kelly WC; Garg S
    Expert Rev Med Devices; 2008 Mar; 5(2):113-23. PubMed ID: 18331174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin pen needles: effects of extra-thin wall needle technology on preference, confidence, and other patient ratings.
    Aronson R; Gibney MA; Oza K; Bérubé J; Kassler-Taub K; Hirsch L
    Clin Ther; 2013 Jul; 35(7):923-933.e4. PubMed ID: 23790553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the dose accuracy of prefilled insulin pens.
    Weise A; Pfützner JW; Borig J; Pfützner AM; Safinowski M; Hänel H; Musholt PB; Pfützner A
    J Diabetes Sci Technol; 2009 Jan; 3(1):149-53. PubMed ID: 20046658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injecting without pressing a button: An exploratory study of a shield-triggered injection mechanism.
    Zijlstra E; Coester HV; Heise T; Plum-Mörschel L; Rasmussen O; Rikte T; Pedersen LK; Qvist M; Sparre T
    Diabetes Obes Metab; 2018 May; 20(5):1140-1147. PubMed ID: 29369493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of adherence and healthcare costs of insulin device (FlexPen) versus conventional vial/syringe.
    Baser O; Bouchard J; DeLuzio T; Henk H; Aagren M
    Adv Ther; 2010 Feb; 27(2):94-104. PubMed ID: 20352392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing accuracy of two insulin pre-filled pens.
    Asakura T; Seino H; Kageyama M; Yohkoh N
    Curr Med Res Opin; 2008 May; 24(5):1429-34. PubMed ID: 18400146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.